<DOC>
	<DOC>NCT00904878</DOC>
	<brief_summary>A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 4 years from birth.</brief_summary>
	<brief_title>A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease</brief_title>
	<detailed_description>All pregnant women with IBD diagnosis who are taking biologics medicines and immunosuppressants will be entered in the study.</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy Pregnant female patients younger than 18 years of age Confirmed multiple gestation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>pregnant IBD patients</keyword>
</DOC>